Vidhya Karivedu
Experienced in Polymorphous Low Grade Adenocarcinoma

Dr. Vidhya Karivedu

Otolaryngology
Duke Health
Duke Raleigh Hematology Oncology Clinic
3404 Wake Forest Rd, 
Raleigh, NC 
Accepting New Patients
Offers Telehealth

Experienced in Polymorphous Low Grade Adenocarcinoma
Duke Health
Duke Raleigh Hematology Oncology Clinic
3404 Wake Forest Rd, 
Raleigh, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

I am a medical oncologist who primarily treats patients with head and neck cancer and lung cancer. I also do clinical research trials. I believe that it’s important to provide all the available treatment options to the patients including clinical trials before we mutually agree on a treatment plan. My primary goal is to provide exceptional care to my patients as well as their families. My focus is compassionate patient care tailored to each individual patient. I am constantly inspired and motivated by my patients and families, and I am very excited to be part of Duke team. Outside of medicine, I like spending time with my husband and daughter, and outdoor activities.

Dr. Karivedu is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Teratocarcinosarcoma, Sinus Cancer, Thyroidectomy, and Gastrostomy.

Her clinical research consists of co-authoring 23 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Otolaryngology
Licenses
Internal Medicine in OH
Board Certifications
American Board Of Internal Med, Hematology
American Board Of Internal Med, Medical Oncology
American Board Of Internal Med, Internal Medicine
Fellowships
Hematology/Oncology, University of Cincinnati (Ohio)
Hospital Affiliations
Duke University Hospital
Languages Spoken
English
American Sign Language
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

Duke Raleigh Hematology Oncology Clinic
3404 Wake Forest Rd, Raleigh, NC 27609
Call: 919-862-5400

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

An Open-Label, Phase III Study of Platinum-Gemcitabine With or Without Nivolumab in the First-Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
An Open-Label, Phase III Study of Platinum-Gemcitabine With or Without Nivolumab in the First-Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
Enrollment Status: Terminated
Publish Date: October 03, 2025
Intervention Type: Drug, Biological, Other
Study Drugs: Carboplatin, Cisplatin, Gemcitabine, Nivolumab
Study Phase: Phase 3
An Open-label, Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients
An Open-label, Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients
Enrollment Status: Active_not_recruiting
Publish Date: August 01, 2024
Intervention Type: Drug
Study Drugs: Niraparib, Dostarlimab
Study Phase: Phase 2
View 1 Less Clinical Trial

23 Total Publications

Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Journal: Cancer research communications
Published: April 20, 2025
View All 23 Publications
Similar Doctors
Advanced in Polymorphous Low Grade Adenocarcinoma
Dr. Trevor G. Hackman
Otolaryngology
Advanced in Polymorphous Low Grade Adenocarcinoma
Dr. Trevor G. Hackman
Otolaryngology

University Of North Carolina At Chapel Hill

101 Manning Dr, 
Chapel Hill, NC 
 (24.9 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Trevor Hackman is an Otolaryngologist in Chapel Hill, North Carolina. Dr. Hackman is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Gland Tumors, Sialadenitis, Laryngectomy, and Gastrostomy. Dr. Hackman is currently accepting new patients.

Neal E. Ready
Advanced in Polymorphous Low Grade Adenocarcinoma
Dr. Neal E. Ready
Otolaryngology
Advanced in Polymorphous Low Grade Adenocarcinoma
Dr. Neal E. Ready
Otolaryngology

Duke Cancer Center

20 Duke Medicine Cir, 
Durham, NC 
 (21.6 miles away)
919-681-6900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

I am a medical oncologist and researcher who specializes in treating patients with lung cancer and head and neck cancer. I’ve been at Duke for eight years. I first realized I wanted to become a doctor in graduate school, because it gave me the opportunity to practically apply scientific evidence to help others. What I love most about my job is working with our research and clinical staff to come up with new and hopeful therapies for patients. When a patient comes to see me, I look at their past and current medical history, review their lab tests, and then work with a team to figure out which treatment would work best for them. If a patient comes from far away, we try to make sure we can fit in visits with all the relevant specialists before they leave. Outside of work, I enjoy exercising with friends and spending time with my children at their various activities. Dr. Ready is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Lung Cancer, ALK-Positive Non-Small Cell Lung Cancer, Laryngeal Cancer, and Throat Cancer.

Advanced in Polymorphous Low Grade Adenocarcinoma
Dr. Wendell G. Yarbrough
Otolaryngology
Advanced in Polymorphous Low Grade Adenocarcinoma
Dr. Wendell G. Yarbrough
Otolaryngology

University Of North Carolina At Chapel Hill

101 Manning Dr, 
Chapel Hill, NC 
 (24.9 miles away)
984-974-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Wendell Yarbrough is an Otolaryngologist in Chapel Hill, North Carolina. Dr. Yarbrough is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Frey's Syndrome, Salivary Gland Tumors, Laryngectomy, and Glossectomy. Dr. Yarbrough is currently accepting new patients.

VIEW MORE POLYMORPHOUS LOW GRADE ADENOCARCINOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Karivedu's expertise for a condition
ConditionClose
    • Distinguished
    • Head and Neck Squamous Cell Carcinoma (HNSCC)
      Dr. Karivedu is
      Distinguished
      . Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
      See more Head and Neck Squamous Cell Carcinoma (HNSCC) experts
      • Experienced
      • Acinic Cell Carcinoma of Salivary Glands
        Dr. Karivedu is
        Experienced
        . Learn about Acinic Cell Carcinoma of Salivary Glands.
        See more Acinic Cell Carcinoma of Salivary Glands experts
      • Adenoid Cystic Carcinoma
        Dr. Karivedu is
        Experienced
        . Learn about Adenoid Cystic Carcinoma.
        See more Adenoid Cystic Carcinoma experts
      • Epithelial-Myoepithelial Carcinoma
        Dr. Karivedu is
        Experienced
        . Learn about Epithelial-Myoepithelial Carcinoma.
        See more Epithelial-Myoepithelial Carcinoma experts
      • Gastrostomy
        Dr. Karivedu is
        Experienced
        . Learn about Gastrostomy.
        See more Gastrostomy experts
      • Laryngeal Cancer
        Dr. Karivedu is
        Experienced
        . Learn about Laryngeal Cancer.
        See more Laryngeal Cancer experts
      • Nasopharyngeal Carcinoma
        Dr. Karivedu is
        Experienced
        . Learn about Nasopharyngeal Carcinoma.
        See more Nasopharyngeal Carcinoma experts
      View All 14 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.